From May 31, 2023 to February 26, 2024, the company has repurchased 56,975,656 shares, representing 4.37% for $53.34 million. With this, the company has completed the repurchase of 56,975,656 shares, representing 4.37% for $53.34 million under the buyback announced on May 31, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.884 USD | +0.68% | +0.91% | +5.24% |
Apr. 24 | BioPharma Credit, Unit to Loan up to $100 Million Each to US-based Tarsus Pharmaceuticals | MT |
Apr. 24 | BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals | AN |
1st Jan change | Capi. | |
---|---|---|
+5.24% | 1.08B | |
+3.54% | 12.51B | |
+6.03% | 9.05B | |
-3.71% | 5.35B | |
+8.10% | 5.31B | |
+5.91% | 5.2B | |
+15.18% | 4.33B | |
+10.15% | 4.32B | |
+1.29% | 3.97B | |
+3.79% | 3.85B |
- Stock Market
- Equities
- BPCP Stock
- News BioPharma Credit PLC
- Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.